AI Drug Developer
Source: Beijing News
Beijing News Shell Finance News, January 27th,Pro PharmaAnnouncement: The company and Hangzhou Derui Zhiyao Technology Co., Ltd. (MindRank Ltd.) have recently signed the "Strategic Cooperation Framework Agreement" based on the principles of equality, mutual benefit, and complementary advantages. Both parties have formed a strategic partnership to carry out long-term cooperation on CDMO projects. The "Strategic Cooperation Framework Agreement" signed this time is only a framework agreement, does not involve substantive transactions, does not constitute a related party transaction, and does not constitute a major asset reorganization as stipulated in the "Measures for the Administration of Major Asset Restructuring of Listed Companies." The signing of this strategic cooperation framework agreement does not require approval from the company's board of directors or shareholders' meeting.